Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.490
+0.080 (5.67%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Cyclerion Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 8 | 8 | 29 | 75 | 104 | |
| Market Cap Growth | -17.31% | -0.51% | -71.30% | -61.69% | -28.31% | 39.09% | |
| Enterprise Value | 1 | 5 | -1 | 8 | 16 | 84 | |
| Last Close Price | 1.41 | 3.22 | 3.35 | 13.12 | 34.40 | 61.20 | |
| PS Ratio | 1.92 | 4.08 | - | 96.10 | 18.90 | 45.26 | |
| PB Ratio | 0.55 | 0.92 | 0.73 | 2.73 | 1.54 | 1.75 | |
| P/TBV Ratio | 0.57 | 0.92 | 0.73 | 2.73 | 1.54 | 1.75 | |
| EV/Sales Ratio | 0.32 | 2.64 | - | 27.39 | 3.93 | 36.37 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.77 | |
| Net Debt / Equity Ratio | -0.48 | -0.36 | -0.67 | -1.28 | -1.12 | -0.15 | |
| Net Debt / EBITDA Ratio | - | - | 0.79 | 0.72 | 1.00 | 0.11 | |
| Net Debt / FCF Ratio | 3.32 | 0.75 | 0.36 | 0.33 | 1.48 | 0.12 | |
| Asset Turnover | 0.30 | 0.17 | - | 0.01 | 0.05 | 0.02 | |
| Quick Ratio | 5.32 | 5.23 | 3.63 | 1.77 | 4.88 | 3.22 | |
| Current Ratio | 5.78 | 5.83 | 3.85 | 1.94 | 5.00 | 3.45 | |
| Return on Equity (ROE) | -24.80% | -30.36% | -115.85% | -62.17% | -95.87% | -98.97% | |
| Return on Assets (ROA) | -23.51% | -19.76% | -38.34% | -29.94% | -38.86% | -34.34% | |
| Return on Capital Employed (ROCE) | -38.10% | -41.00% | -85.50% | -177.40% | -112.60% | -84.30% | |
| Earnings Yield | -40.12% | -37.51% | -64.25% | -154.44% | -69.32% | -74.87% | |
| FCF Yield | -25.09% | -53.17% | -259.37% | -142.29% | -49.02% | -71.22% | |
| Buyback Yield / Dilution | -14.72% | -7.70% | -7.59% | -11.03% | -28.75% | -11.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.